These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
FORM
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the quarterly period ended
|
September 28, 2019
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from ________ to ________.
|
|
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
|
(I.R.S. Employer I. D. No.)
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
|
|
|
|
☒
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
Emerging growth company
|
|
|
|
|
|
|
PART I - FINANCIAL INFORMATION
|
|
Page
|
|
|
|
Item 1. Financial Statements (Unaudited)
|
|
|
|
|
|
Condensed Consolidated Balance Sheets as of September 28, 2019 and June 29, 2019
|
|
|
|
|
|
Condensed Consolidated Statements of Income for the Three Months Ended September 28, 2019 and September 29, 2018
|
|
|
|
|
|
Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended September 28, 2019 and September 29, 2018
|
|
|
|
|
|
Condensed Consolidated Statements of Shareholders' Equity for the Three Months Ended September 28, 2019 and September 29, 2018
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 28, 2019 and September 29, 2018
|
|
|
|
|
|
Notes to Condensed Consolidated Financial Statements
|
|
|
|
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
|
|
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
|
|
|
|
|
Item 4. Controls and Procedures
|
|
|
|
|
|
PART II - OTHER INFORMATION
|
|
|
|
|
|
Item 1. Legal Proceedings
|
|
|
|
|
|
Item 1A. Risk Factors
|
|
|
|
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
|
|
|
|
|
Item 3. Defaults Upon Senior Securities
|
|
|
|
|
|
Item 4. Mine Safety Disclosures
|
|
|
|
|
|
Item 5. Other Information
|
|
|
|
|
|
Item 6. Exhibits
|
|
|
|
|
|
SIGNATURE
|
|
|
September 28,
2019 |
|
June 29,
2019 |
||||
|
(in thousands)
|
||||||
ASSETS
|
|||||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
|
|
|
$
|
|
|
Short-term investments
|
|
|
|
|
|
||
Total cash, cash equivalents and short-term investments
|
|
|
|
|
|
||
Accounts receivable, net of allowances of $99 at September 28, 2019 and $148 at June 29, 2019
|
|
|
|
|
|
||
Inventories
|
|
|
|
|
|
||
Other current assets
|
|
|
|
|
|
||
Total current assets
|
|
|
|
|
|
||
Property, plant and equipment, net
|
|
|
|
|
|
||
Intangible assets, net
|
|
|
|
|
|
||
Goodwill
|
|
|
|
|
|
||
Other assets
|
|
|
|
|
|
||
TOTAL ASSETS
|
$
|
|
|
|
$
|
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|||||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
|
|
|
$
|
|
|
Price adjustment and other revenue reserves
|
|
|
|
|
|
||
Income taxes payable
|
|
|
|
|
|
||
Accrued salary and related expenses
|
|
|
|
|
|
||
Accrued expenses
|
|
|
|
|
|
||
Total current liabilities
|
|
|
|
|
|
||
Long-term debt
|
|
|
|
|
|
||
Income taxes payable
|
|
|
|
|
|
||
Other liabilities
|
|
|
|
|
|
||
Total liabilities
|
|
|
|
|
|
||
|
|
|
|
||||
Commitments and contingencies (Note 11)
|
|
|
|
|
|
||
|
|
|
|
||||
Stockholders’ equity:
|
|
|
|
||||
Common stock and capital in excess of par value
|
|
|
|
|
|
||
Retained earnings
|
|
|
|
|
|
||
Accumulated other comprehensive loss
|
(
|
)
|
|
(
|
)
|
||
Total stockholders’ equity
|
|
|
|
|
|
||
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY
|
$
|
|
|
|
$
|
|
|
|
Three Months Ended
|
||||||
|
September 28,
2019 |
|
September 29,
2018 |
||||
|
(in thousands, except per share data)
|
||||||
|
|
|
|
||||
Net revenues
|
$
|
|
|
|
$
|
|
|
Cost of goods sold
|
|
|
|
|
|
||
Gross margin
|
|
|
|
|
|
||
Operating expenses:
|
|
|
|
||||
Research and development
|
|
|
|
|
|
||
Selling, general and administrative
|
|
|
|
|
|
||
Intangible asset amortization
|
|
|
|
|
|
||
Severance and restructuring expenses
|
|
|
|
|
|
||
Other operating expenses (income), net
|
|
|
|
|
|
||
Total operating expenses
|
|
|
|
|
|
||
Operating income
|
|
|
|
|
|
||
Interest and other income (expense), net
|
|
|
|
(
|
)
|
||
Income before provision for income taxes
|
|
|
|
|
|
||
Income tax provision
|
|
|
|
|
|
||
Net income
|
$
|
|
|
|
$
|
|
|
|
|
|
|
||||
Earnings per share:
|
|
|
|
||||
Basic
|
$
|
|
|
|
$
|
|
|
Diluted
|
$
|
|
|
|
$
|
|
|
|
|
|
|
||||
Shares used in the calculation of earnings per share:
|
|
|
|
||||
Basic
|
|
|
|
|
|
||
Diluted
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
September 28,
2019 |
|
September 29,
2018 |
||||
|
(in thousands)
|
||||||
Net income
|
$
|
|
|
|
$
|
|
|
Other comprehensive income (loss), net of tax:
|
|
|
|
||||
Change in net unrealized gains and losses on available-for-sale securities, net of tax benefit (expense) of $(14) and $(27), respectively
|
|
|
|
|
|
||
Change in net unrealized gains and losses on cash flow hedges, net of tax benefit (expense) of $165 and $(214), respectively
|
(
|
)
|
|
|
|
||
Change in net unrealized gains and losses on post-retirement benefits, net of tax benefit (expense) of $(22) and $(19), respectively
|
|
|
|
|
|
||
Other comprehensive income (loss), net
|
(
|
)
|
|
|
|
||
Total comprehensive income
|
$
|
|
|
|
$
|
|
|
|
Three Months Ended September 28, 2019
|
|||||||||||||||||||||
|
Common Stock
|
|
Additional Paid-In Capital
|
|
Retained Earnings
|
|
Accumulated Other Comprehensive Loss
|
|
Total
Stockholders' Equity
|
|||||||||||||
|
Shares
|
|
Par Value
|
|
|
|
|
|||||||||||||||
|
(in thousands)
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance, June 29, 2019
|
|
|
|
$
|
|
|
|
$
|
—
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
Net income
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|||||
Other comprehensive income (loss), net
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
(
|
)
|
|||||
Repurchase of common stock
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||||
Cumulative-effect adjustment for adoption of ASU 2016-02
|
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
—
|
|
|
(
|
)
|
|||||
Net issuance of restricted stock units
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|||||
Stock options exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Dividends paid, $0.48 per common share
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||||
Balance, September 28, 2019
|
|
|
|
$
|
|
|
|
$
|
—
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 29, 2018
|
|||||||||||||||||||||
|
Common Stock
|
|
Additional Paid-In Capital
|
|
Retained Earnings
|
|
Accumulated Other Comprehensive Loss
|
|
Total
Stockholders' Equity
|
|||||||||||||
|
Shares
|
|
Par Value
|
|
|
|
|
|||||||||||||||
|
(in thousands)
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance, June 30, 2018
|
|
|
|
$
|
|
|
|
$
|
—
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
Net income
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|||||
Other comprehensive income (loss), net
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|||||
Repurchase of common stock
|
(
|
)
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||||
Cumulative-effect adjustment for adoption of ASU 2016-01
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|||||
Net issuance of restricted stock units
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|||||
Stock options exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Dividends paid, $0.46 per common share
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||||
Balance, September 29, 2018
|
|
|
|
$
|
|
|
|
$
|
—
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
September 28,
2019 |
|
September 29,
2018 |
||||
|
(in thousands)
|
||||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
|
|
|
$
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Stock-based compensation
|
|
|
|
|
|
||
Depreciation and amortization
|
|
|
|
|
|
||
Deferred taxes
|
|
|
|
(
|
)
|
||
Loss (gain) on disposal of property, plant and equipment
|
|
|
|
|
|
||
Other adjustments
|
|
|
|
(
|
)
|
||
Changes in assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
(
|
)
|
|
(
|
)
|
||
Inventories
|
|
|
|
|
|
||
Other current assets
|
(
|
)
|
|
(
|
)
|
||
Accounts payable
|
|
|
|
(
|
)
|
||
Income taxes payable
|
(
|
)
|
|
|
|
||
Accrued salary and related expenses
|
(
|
)
|
|
(
|
)
|
||
All other accrued liabilities
|
|
|
|
|
|
||
Net cash provided by (used in) operating activities
|
|
|
|
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Purchases of property, plant and equipment
|
(
|
)
|
|
(
|
)
|
||
Proceeds from sale of property, plant and equipment
|
|
|
|
|
|
||
Proceeds from sale of available-for-sale securities
|
|
|
|
|
|
||
Proceeds from maturity of available-for-sale securities
|
|
|
|
|
|
||
Payment in connection with business acquisition, net of cash acquired
|
|
|
|
(
|
)
|
||
Purchases of available-for-sale securities
|
|
|
|
(
|
)
|
||
Purchases of private company investments
|
|
|
|
(
|
)
|
||
Proceeds from private company investments
|
|
|
|
|
|
||
Other investing activities
|
(
|
)
|
|
|
|
||
Net cash provided by (used in) investing activities
|
|
|
|
|
|
||
Cash flows from financing activities:
|
|
|
|
||||
Contingent consideration paid
|
|
|
|
(
|
)
|
||
Net issuance of restricted stock units
|
(
|
)
|
|
(
|
)
|
||
Proceeds from stock options exercised
|
|
|
|
|
|
||
Repurchase of common stock
|
(
|
)
|
|
(
|
)
|
||
Dividends paid
|
(
|
)
|
|
(
|
)
|
||
Net cash provided by (used in) financing activities
|
(
|
)
|
|
(
|
)
|
||
Net increase (decrease) in cash and cash equivalents
|
(
|
)
|
|
|
|
||
Cash and cash equivalents:
|
|
|
|
||||
Beginning of period
|
$
|
|
|
|
$
|
|
|
End of period
|
$
|
|
|
|
$
|
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
||||
Cash paid, net, during the period for income taxes
|
$
|
|
|
|
$
|
|
|
Cash paid for interest
|
$
|
|
|
|
$
|
|
|
Noncash financing and investing activities:
|
|
|
|
||||
Accounts payable related to property, plant and equipment purchases
|
$
|
|
|
|
$
|
|
|
•
|
the hindsight practical expedient, in which the Company elected to use hindsight up until the effective date in determining the lease term and assessing impairment of right-of-use assets;
|
•
|
the practical expedient package that allows the Company to carry forward its determination of whether a lease exists, the classification of a lease, and whether initial direct lease costs exist for purposes of transition to the new standard; and
|
•
|
the practical expedient to combine lease and non-lease components.
|
|
September 28,
2019 |
|
June 29,
2019 |
||||
|
(in thousands)
|
||||||
Raw materials
|
$
|
|
|
|
$
|
|
|
Work-in-process
|
|
|
|
|
|
||
Finished goods
|
|
|
|
|
|
||
Total inventories
|
$
|
|
|
|
$
|
|
|
|
September 28,
2019 |
|
June 29,
2019 |
||||
|
(in thousands)
|
||||||
Land
|
$
|
|
|
|
$
|
|
|
Buildings and building improvements
|
|
|
|
|
|
||
Machinery, equipment and software
|
|
|
|
|
|
||
Total
|
|
|
|
|
|
||
Less: accumulated depreciation
|
(
|
)
|
|
(
|
)
|
||
Total property, plant and equipment, net
|
$
|
|
|
|
$
|
|
|
|
September 28,
2019 |
|
June 29,
2019 |
||||
|
(in thousands)
|
||||||
Accrued vacation
|
$
|
|
|
|
$
|
|
|
Accrued bonus
|
|
|
|
|
|
||
Accrued salaries
|
|
|
|
|
|
||
Accrued fringe benefits
|
|
|
|
|
|
||
Other
|
|
|
|
|
|
||
Total accrued salary and related expenses
|
$
|
|
|
|
$
|
|
|
|
September 28, 2019
|
|
June 29, 2019
|
||||||||||||||||||||||||||||
|
Fair Value
Measurements Using
|
|
Total
Balance |
|
Fair Value
Measurements Using
|
|
Total
Balance |
||||||||||||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
||||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||||||||||||
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Cash and cash equivalents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Money market funds
|
$
|
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Short-term investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Certificates of deposit
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
||||||||
Corporate debt securities
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
||||||||
Other current assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Foreign currency forward contracts
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Total assets
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Accrued expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Foreign currency forward contracts
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Contingent consideration
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
||||||||
Total Liabilities
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
September 28, 2019
|
|
June 29, 2019
|
||||||||||||||||||||||||||||
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Estimated Fair Value
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Estimated Fair Value
|
||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||||||||||||
Available-for-sale investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Certificates of deposit
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Corporate debt securities
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
||||||||
Total available-for-sale investments
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Three Months Ended
|
Three Months Ended
|
|||||||||||||||||||||
|
September 28, 2019
|
September 29, 2018
|
|||||||||||||||||||||
|
Net Revenue
|
|
Cost of Goods Sold
|
|
Operating Expenses
|
|
Net Revenue
|
|
Cost of Goods Sold
|
|
Operating Expenses
|
||||||||||||
|
(in thousands)
|
||||||||||||||||||||||
Income and expenses line items in which the effects of cash flow hedges are recorded
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Gain (loss) on cash flow hedges:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Foreign exchange contracts:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Gain (loss) reclassified from accumulated other comprehensive income into income
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
September 28, 2019
|
|
June 29, 2019
|
||||
|
(in thousands)
|
||||||
3.45% fixed rate notes due June 2027
|
$
|
|
|
|
$
|
|
|
3.375% fixed rate notes due March 2023
|
|
|
|
|
|
||
Total outstanding debt
|
|
|
|
|
|
||
Less: Reduction for unamortized discount and debt issuance costs
|
(
|
)
|
|
(
|
)
|
||
Total long-term debt
|
$
|
|
|
|
$
|
|
|
|
Three Months Ended
|
|
Three Months Ended
|
||||||||||||||||||||||||||||
|
September 28, 2019
|
|
September 29, 2018
|
||||||||||||||||||||||||||||
|
Stock Options
|
|
Restricted Stock Units
|
|
Employee Stock Purchase Plan
|
|
Total
|
|
Stock Options
|
|
Restricted Stock Units
|
|
Employee Stock Purchase Plan
|
|
Total
|
||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||||||||||||
Cost of goods sold
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Research and development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Selling, general and administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Pre-tax stock-based compensation expense
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Less: income tax effect
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Net stock-based compensation expense
|
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
$
|
|
|
|
Number of
Shares
|
|
Weighted Average Exercise Price
|
|
Weighted Average Remaining Contractual Term (in Years)
|
|
Aggregate Intrinsic Value
(1)
|
|||||
Balance at June 29, 2019
|
|
|
|
$
|
|
|
|
|
|
|
||
Options Granted
|
|
|
|
|
|
|
|
|
|
|||
Options Exercised
|
(
|
)
|
|
|
|
|
|
|
|
|||
Options Cancelled
|
(
|
)
|
|
|
|
|
|
|
|
|||
Balance at September 28, 2019
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
Exercisable, September 28, 2019
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
Vested and expected to vest, September 28, 2019
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
(1)
|
Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on September 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of September 28, 2019.
|
|
Number of
Shares
|
|
Weighted Average
Remaining Contractual Term (in Years) |
|
Aggregate Intrinsic
Value
(1)
|
|||
Balance at June 29, 2019
|
|
|
|
|
|
|
||
Restricted stock units and other awards granted
|
|
|
|
|
|
|
||
Restricted stock units and other awards released
|
(
|
)
|
|
|
|
|
||
Restricted stock units and other awards cancelled
|
(
|
)
|
|
|
|
|
||
Balance at September 28, 2019
|
|
|
|
|
|
$
|
|
|
Outstanding and expected to vest, September 28, 2019
|
|
|
|
|
|
$
|
|
|
(1)
|
Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on September 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of September 28, 2019.
|
|
Number of
Shares
|
|
Weighted Average
Remaining Contractual Term (in Years) |
|
Aggregate Intrinsic
Value (1) |
|||
Balance at June 29, 2019
|
|
|
|
|
|
|
||
Market stock units granted
|
|
|
|
|
|
|
||
Market stock units released
|
(
|
)
|
|
|
|
|
||
Market stock units cancelled
|
(
|
)
|
|
|
|
|
||
Balance at September 28, 2019
|
|
|
|
|
|
$
|
|
|
Outstanding and expected to vest, September 28, 2019
|
|
|
|
|
|
$
|
|
|
(1)
|
Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on September 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of September 28, 2019.
|
|
Three Months Ended
|
||
|
September 28, 2019
|
|
September 29, 2018
|
Expected holding period (in years)
|
|
|
|
Risk-free interest rate
|
2.3% - 2.7%
|
|
1.6% - 2.1%
|
Expected stock price volatility
|
29.5 % - 31.3%
|
|
19.6% - 32.7%
|
Dividend yield
|
3.1% - 3.4%
|
|
2.8% - 3.1%
|
|
Three Months Ended
|
||||||
|
September 28,
2019 |
|
September 29,
2018 |
||||
|
(in thousands, except per share data)
|
||||||
Numerator for basic earnings per share and diluted earnings per share
|
|
|
|
||||
Net income
|
$
|
140,156
|
|
|
$
|
197,423
|
|
|
|
|
|
||||
Denominator for basic earnings per share
|
|
|
|
|
|
||
Effect of dilutive securities:
|
|
|
|
||||
Stock options, ESPP, RSUs, and MSUs
|
|
|
|
|
|
||
Denominator for diluted earnings per share
|
|
|
|
|
|
||
|
|
|
|
||||
Earnings per share
|
|
|
|
||||
Basic
|
$
|
|
|
|
$
|
|
|
Diluted
|
$
|
|
|
|
$
|
|
|
|
Three Months Ended
|
||||||
|
September 28,
2019 |
|
September 29,
2018 |
||||
|
(in thousands)
|
||||||
United States
|
$
|
|
|
|
$
|
|
|
China
|
|
|
|
|
|
||
Rest of Asia
|
|
|
|
|
|
||
Europe
|
|
|
|
|
|
||
Rest of World
|
|
|
|
|
|
||
|
$
|
|
|
|
$
|
|
|
|
September 28,
2019 |
|
June 29,
2019 |
||||
|
(in thousands)
|
||||||
United States
|
$
|
|
|
|
$
|
|
|
Philippines
|
|
|
|
|
|
||
Rest of World
|
|
|
|
|
|
||
|
$
|
|
|
|
$
|
|
|
(in thousands)
|
Unrealized Gains and (Losses) on Intercompany Receivables
|
|
Unrealized Gains and (Losses) on Post-Retirement Benefits
|
|
Cumulative Translation Adjustment
|
|
Unrealized Gains and (Losses) on Cash Flow Hedges
|
|
Unrealized Gains and (Losses) on Available-For-Sale Securities
|
|
Total
|
||||||||||||
June 29, 2019
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
Other comprehensive income (loss) before reclassifications
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
Amounts reclassified out of accumulated other comprehensive (income) loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Tax effects
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
||||||
Other comprehensive income (loss), net
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
September 28, 2019
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
(in thousands)
|
Unrealized Gains and (Losses) on Intercompany Receivables
|
|
Unrealized Gains and (Losses) on Post-Retirement Benefits
|
|
Cumulative Translation Adjustment
|
|
Unrealized Gains and (Losses) on Cash Flow Hedges
|
|
Unrealized Gains and (Losses) on Available-For-Sale Securities
|
|
Total
|
||||||||||||
June 30, 2018
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
Other comprehensive income (loss) before reclassifications
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||
Amounts reclassified out of accumulated other comprehensive (income) loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Tax effects
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||||
Other comprehensive income (loss), net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
September 29, 2018
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
|
September 28, 2019
|
||
|
|
(in thousands)
|
||
Other assets
|
|
$
|
|
|
|
|
|
||
Accrued expenses
|
|
$
|
|
|
Other liabilities
|
|
$
|
|
|
|
|
Operating Lease Obligations
|
||
Fiscal Year
|
|
(in thousands)
|
||
Remainder of 2020
|
|
$
|
|
|
2021
|
|
|
|
|
2022
|
|
|
|
|
2023
|
|
|
|
|
2024
|
|
|
|
|
Thereafter
|
|
|
|
|
Total
|
|
|
|
|
Less imputed interest
|
|
|
|
|
Total
|
|
$
|
|
|
|
|
Three Months Ended
|
||
|
|
September 28, 2019
|
||
Supplemental cash flow information
|
|
(in thousands)
|
||
Operating cash flows used for operating leases
|
|
$
|
|
|
Weighted-average remaining lease term - operating leases, in years
|
|
|
|
|
Weighted-average discount rate - operating leases
|
|
|
%
|
|
September 28, 2019
|
|
June 29, 2019
|
||||||||||||||||||||
|
Original
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
Original
Cost
|
|
Accumulated
Amortization
|
|
Net
|
||||||||||||
|
(in thousands)
|
||||||||||||||||||||||
Intellectual property
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Customer relationships
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Trade name
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Patents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total amortizable purchased intangible assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
In-process research & development (IPR&D)
|
|
|
|
—
|
|
|
|
|
|
|
|
|
—
|
|
|
|
|
||||||
Total purchased intangible assets
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Three Months Ended
|
||||||
|
September 28,
2019 |
|
September 29,
2018 |
||||
|
(in thousands)
|
||||||
Cost of goods sold
|
$
|
|
|
|
$
|
|
|
Intangible asset amortization
|
|
|
|
|
|
||
Total intangible asset amortization expenses
|
$
|
|
|
|
$
|
|
|
|
|
Amount
|
||
Fiscal Year
|
|
(in thousands)
|
||
Remaining nine months of 2020
|
|
$
|
|
|
2021
|
|
|
|
|
2022
|
|
|
|
|
2023
|
|
|
|
|
2024
|
|
|
|
|
Thereafter
|
|
|
|
|
Total intangible assets
|
|
$
|
|
|
•
|
digital devices, such as memories and microprocessors that operate primarily in the digital domain;
|
•
|
linear devices, such as amplifiers, references, analog multiplexers and switches that operate primarily in the analog domain; and
|
•
|
mixed-signal devices such as data converter devices that combine linear and digital functions on the same integrated circuit and interface between the analog and digital domains.
|
MAJOR END-MARKET
|
|
MARKET
|
|
|
|
|
|
AUTOMOTIVE
|
Infotainment
|
|
|
|
Powertrain
|
|
|
|
Body Electronics
|
|
|
|
Safety and Security
|
|
|
|
|
|
|
COMMUNICATIONS & DATA CENTER
|
Base Stations
|
|
|
|
Data Center
|
|
|
|
Data Storage
|
|
|
|
Desktop Computers
|
|
|
|
Network & Datacom
|
|
|
|
Notebook Computers
|
|
|
|
Peripherals & Other Computer
|
|
|
|
Server
|
|
|
|
Telecom
|
|
|
|
Other Communications
|
|
|
|
|
|
|
CONSUMER
|
Smartphones
|
|
|
|
Digital Cameras
|
|
|
|
Handheld Computers
|
|
|
|
Home Entertainment & Appliances
|
|
|
|
Wearables
|
|
|
|
Other Consumer
|
|
|
|
|
|
|
INDUSTRIAL
|
Automatic Test Equipment
|
|
|
|
Control & Automation
|
|
|
|
Electrical Instrumentation
|
|
|
|
Financial Terminals
|
|
|
|
Medical
|
|
|
|
Security
|
|
|
|
USB Extension
|
|
|
|
Other Industrial
|
|
|
Three Months Ended
|
||||
|
September 28,
2019 |
|
September 29,
2018 |
||
|
|
|
|
||
Net revenues
|
100.0
|
%
|
|
100.0
|
%
|
Cost of goods sold
|
35.6
|
%
|
|
32.6
|
%
|
Gross margin
|
64.4
|
%
|
|
67.4
|
%
|
Operating expenses:
|
|
|
|
||
Research and development
|
20.4
|
%
|
|
17.7
|
%
|
Selling, general and administrative
|
14.3
|
%
|
|
12.8
|
%
|
Intangible asset amortization
|
0.1
|
%
|
|
0.1
|
%
|
Severance and restructuring expenses
|
0.3
|
%
|
|
0.2
|
%
|
Other operating expenses (income), net
|
—
|
%
|
|
—
|
%
|
Total operating expenses
|
35.1
|
%
|
|
30.7
|
%
|
Operating income
|
29.3
|
%
|
|
36.7
|
%
|
Interest and other income (expense), net
|
0.3
|
%
|
|
(0.1
|
)%
|
Income before provision for income taxes
|
29.6
|
%
|
|
36.6
|
%
|
Income tax provision (benefit)
|
3.3
|
%
|
|
5.7
|
%
|
Net income
|
26.3
|
%
|
|
30.9
|
%
|
|
Three Months Ended
|
||||
|
September 28,
2019 |
|
September 29,
2018 |
||
Cost of goods sold
|
0.6
|
%
|
|
0.5
|
%
|
Research and development
|
2.0
|
%
|
|
1.4
|
%
|
Selling, general and administrative
|
2.0
|
%
|
|
1.2
|
%
|
|
4.6
|
%
|
|
3.1
|
%
|
|
Three Months Ended
|
||||||
|
September 28,
2019 |
|
September 29,
2018 |
||||
|
(in thousands)
|
||||||
Net cash provided by (used in) operating activities
|
$
|
141,270
|
|
|
$
|
207,185
|
|
Net cash provided by (used in) investing activities
|
22,814
|
|
|
97,378
|
|
||
Net cash provided by (used in) financing activities
|
(226,235
|
)
|
|
(249,275
|
)
|
||
Net increase (decrease) in cash and cash equivalents
|
$
|
(62,151
|
)
|
|
$
|
55,288
|
|
|
Issuer Repurchases of Equity Securities
|
||||||||||||
|
(in thousands, except per share amounts)
|
||||||||||||
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
|
||||||
Jun 30, 2019 - Jul 27, 2019
|
436
|
|
|
$
|
61.35
|
|
|
436
|
|
|
$
|
1,088,234
|
|
Jul 28, 2019 - Aug 24, 2019
|
531
|
|
|
56.22
|
|
|
531
|
|
|
1,058,397
|
|
||
Aug 25, 2019 - Sep 28, 2019
|
655
|
|
|
56.45
|
|
|
655
|
|
|
1,021,431
|
|
||
Total for the quarter
|
1,622
|
|
|
$
|
57.69
|
|
|
1,622
|
|
|
$
|
1,021,431
|
|
101.INS
|
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
(1)
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document
(1)
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
(1)
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
(1)
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document
(1)
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
(1)
|
104
|
Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
(1)
|
(1) Filed or furnished herewith.
|
October 30, 2019
|
|
MAXIM INTEGRATED PRODUCTS, INC.
|
|
|
|
|
|
By:/s/ Brian C. White
|
|
|
Brian C. White
|
|
|
Senior Vice President, Chief Financial Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
IES Holdings, Inc. | IESC |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|